HCPCS Codes Similar to M1484

HCPCS Codes Similar to “M1484” Code.
Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis)

G9384 Documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [i.e., ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons) Code added date: 20150101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9940 Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year) Code added date: 20180101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
G9504 Documented reason for not assessing hepatitis b virus (hbv) status (e.g., patient not initiating anti-tnf therapy, patient declined) prior to initiating anti-tnf therapy Code added date: 20160101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9915 No record of hbv results documented Code added date: 20180101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
G9912 Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy Code added date: 20180101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9913 Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified Code added date: 20180101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
G8535 Elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter related to one of the following reasons: (1) patient refuses to participate in the screening and has reasonable decisional capacity for self-protection, or (2) patient is in an urgent or emergent situation where time is of the essence and to delay treatment to perform the screening would jeopardize the patient's health status Code added date: 20090101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	M1414 Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication) Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1377 Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patient Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	C7553 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed Code added date: 20230101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
C7558 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed Code added date: 20240101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	G8430 Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) Code added date: 20080101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON
H2037 Developmental delay prevention activities, dependent child of client, per 15 minutes Code added date: 20030401 Code effective date: 20030401 TXT \| PDF \| XML \| JSON	S3870 Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability Code added date: 20090401 Code effective date: 20140101 TXT \| PDF \| XML \| JSON